Helicobacter pylori IgG Helicobacter pylori is a harmful bacterium that infects the gastric mucosa, causing gastritis, gastric and duodenal ulcers, gastric carcinoma, and ulcerative esophagitis
"Bear in mind that these drugs are not a first-line defense against mild weight gain
The FDAs approval was based on results from the Phase III CheckMate901 trial, where the combo regimen demonstrated a statistically significant improvement in overall survival and progression-free survival compared to cisplatin-gemcitabine alone, BMS reported
While the early data is promising: There are no large randomized controlled trials in lipedema Most evidence comes from small studies or related conditions These medications are not currently approved specifically for lipedema However, they may be helpful for some individuals , particularly those with: Insulin resistance Weight gain alongside lipedema Significant inflammation or metabolic dysfunction Why Nutrition Still Matters with GLP-1 Medications GLP-1 medications are not a standalone solution
As of May 2025, obtaining compounded semaglutide has become significantly restricted